SCHEMBL22397018

SCHEMBL22397018

O=C(O)COc1cccc(C(F)(F)F)n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
P2RX7 Q99572 1/20 0.46
MEN1 O00255 1/20 0.46
PKM P14618 1/20 0.46
PTGDR2 Q9Y5Y4 4/20 0.43
ALOX15 P16050 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.40
CD69 Q07108 2/20 0.40
HTT P42858 1/20 0.40
LOXL2 Q9Y4K0 2/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN7 P35236 1/20 0.39
PTGDR Q13258 1/20 0.39
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32682038 1.00 KMT2A (0.46) KMT2AP2RX7MEN1PKMPTGDR2
SCHEMBL17117512 0.86 P2RX7 (0.45) P2RX7TAS2R14LOXL2
SCHEMBL17109775 0.83 P2RX7 (0.43) P2RX7ALDH1A1HTTSMN1; SMN2
SCHEMBL20427990 0.82 P2RX7 (0.42) P2RX7
SCHEMBL22396731 0.81 PSEN1 (0.42) P2RX7KDM4EALDH1A1SMN1; SMN2
SCHEMBL7640840 0.80 P2RX7 (0.38) P2RX7TAS2R14LOXL2
SCHEMBL31287374 0.79 CFD (0.42) P2RX7PTGDR2TDP1TAS2R14
SCHEMBL16834262 0.78 P2RX7 (0.46) P2RX7KDM4EHPGDTAS2R14LOXL2
SCHEMBL13064185 0.76 GRM5 (0.50) P2RX7KDM4EHPGDLMNA
SCHEMBL31608506 0.76 GRM5 (0.50) P2RX7KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-05-23 US disclosed
CN-112189008-A Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2021-01-05 CN disclosed
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 US disclosed
EP-3704094-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2020-09-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 KMT2A 4320/4885P2RX7 3683/4885MEN1 4714/4885
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 KMT2A 4320/4885P2RX7 3683/4885MEN1 4714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.